ERBB2 and breast cancer: Because breast cancer before age 50 precedes the average age of diagnosis, the increased risk with higher levels of p,p ́-DDT suggests an effect on latency similar to that observed with p,p ́-DDE and o,p ́-DDE in MMTV-Neu mice.